Cartesian Therapeutics (RNAC) Share-based Compensation (2018 - 2026)
Cartesian Therapeutics' Share-based Compensation was $2.08 million in Q2 2026, down 36.5% from $3.28 million a year earlier and down 14.0% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Share-based Compensation (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cartesian Therapeutics' Share-based Compensation was $9.24 million through Jun 30, 2026, down 1.1% year-over-year; for FY2025, it came in at $10.52 million, up 59.8% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $6.58 million in FY2024 (-70.8%), $22.52 million in FY2023 (+101.2%), $11.19 million in FY2022 (+45.0%) and $7.72 million in FY2021 (+42.4%).
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2024.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 11.9%.
- The best year-over-year quarter for Share-based Compensation over five years was Q4 2023 (growth of 521.4%); the worst was Q4 2024 (a decline of 86.8%).
- Per Business Quant data, RNAC's Share-based Compensation in the three quarters before Q2 2026 was $2.42 million (Q1 2026), $2.14 million (Q4 2025) and $2.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | 2.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 14.14 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | 1.90 Mn |
API Access
Cartesian Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();